Immune system polymorphisms and factor VIII inhibitor formation in Brazilian haemophilia A severe patients

被引：6
|
作者：
Agostini, D. [1 ]
Rosset, C. [1 ]
Botton, M. R. [1 ]
Kappel, D. B. [1 ]
Vieira, I. A. [1 ]
Gorziza, R. P. [1 ]
Salzano, F. M. [1 ]
Bandinelli, E. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil
来源：
HAEMOPHILIA | 2012年 / 18卷 / 06期
关键词：
DISEASE; IMPACT; GENES;
D O I：
10.1111/hae.12015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e416 / e418
页数：3
相关论文
共 50 条
  • [21] Cumulative analysis of inhibitor formation in patients with haemophilia A treated with sucrose-formulated recombinant factor VIII
    Bajwa, N.
    Enriquez, M. M.
    Gorina, E.
    Lemm, G.
    HAEMOPHILIA, 2009, 15 (02) : 597 - 600
  • [22] Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors
    Batlle, J
    López, MF
    Brackmann, HH
    Gaillard, S
    Goudemand, J
    Humbert, J
    De Moerloose, P
    Maass, E
    Mauz-Körholz, C
    Sultan, Y
    Stieltjes, N
    HAEMOPHILIA, 1999, 5 (06) : 431 - 435
  • [23] A transient high titer inhibitor in a boy with severe haemophilia A treated with recombinant factor VIII
    Gottstein, S.
    Budde, U.
    Klamroth, R.
    HAMOSTASEOLOGIE, 2009, 29 : S61 - S61
  • [24] Sclerotherapy of esophageal varices in severe haemophilia a patient and factor VIII high titre inhibitor
    Szczepanik, A. B.
    Dabrowski, W. P.
    Szczepanik, A. M.
    Jaskowiak, W.
    Pielacinski, K.
    Misiak, A.
    HAEMOPHILIA, 2013, 19 : 73 - 74
  • [25] Update of the risk of inhibitor occurrence at first treatment by a Factor VIII concentrate in severe haemophilia A
    Chambost, H.
    Guillaume, Y.
    Falaise, C.
    Roux, C.
    Monpoux, F.
    REVUE D ONCOLOGIE HEMATOLOGIE PEDIATRIQUE, 2015, 3 (02): : 78 - 87
  • [26] Continuous infusion of recombinant porcine factor VIII for neurosurgical management of intracranial haemorrhage in a patient with severe haemophilia A with factor VIII inhibitor
    Ruan, Gordon J.
    Mao, Jimmy J.
    Sytsma, Terin T.
    Akogyeram, Ivy I.
    Wang, Yucai
    Ashrani, Aneel A.
    Pruthi, Rajiv K.
    HAEMOPHILIA, 2020, 26 (03) : E141 - E144
  • [27] Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
    Reipert, Birgit M.
    van den Helden, Patiline M. W.
    Schwarz, Hans-Peter
    Hausl, Christina
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 12 - 25
  • [28] Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A
    Bidlingmaier, C.
    Kurnik, K.
    Escuriola-Ettingshausen, C.
    Jager, R.
    Klamroth, R.
    Male, C.
    Marosi, A.
    Nemes, L.
    Von Stackelberg, A.
    Kreuz, W.
    HAEMOPHILIA, 2011, 17 (05) : E837 - E840
  • [29] Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII gene
    Tizzano, EF
    Altisent, C
    Domenech, M
    Cornet, M
    Tusell, J
    Baiget, M
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (01) : 125 - 126
  • [30] High titre inhibitor to factor VIII in a haemophilia carrier
    Marino, R.
    Malcangi, G.
    Margaglione, M.
    Ettorre, C. P.
    HAEMOPHILIA, 2014, 20 (03) : E237 - E240
12345